Form 4: Elanco CEO Jeffrey Simmons Acquires Additional Deferred Stock Units

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 185.6059 deferred stock units, increasing his beneficial ownership to 17,220.9125 units.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. (ELAN), acquired 185.6059 Deferred Stock Units.
• The transaction date for the acquisition was July 25, 2025.
• Each deferred stock unit represents the right to receive one share of Company common stock or its cash equivalent.
• The price of the derivative security (Deferred Stock Unit) was $14.92.
• Following this transaction, Mr. Simmons beneficially owns 17,220.9125 Deferred Stock Units directly.
• These units are set to settle in cash or shares of Company common stock upon termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 8

Explanation: The acquisition of additional equity by the CEO is a strong positive signal, indicating confidence in the company's future prospects and aligning executive interests with shareholder value.

Positives

• Acquisition of additional deferred stock units by the CEO indicates continued alignment of management's interests with shareholder value.
• The transaction increases the CEO's direct beneficial ownership in the company.

Future Outlook

NA

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends. It reflects an executive's personal investment in the company's equity.

Related Party Transactions

• The acquisition of deferred stock units by Jeffrey N. Simmons, the President, CEO, and Director, constitutes a related party transaction as it involves an executive's dealings with the company's equity.

Stakeholder Impact

• Shareholders: The transaction may be viewed positively by shareholders as it demonstrates management's commitment and confidence in the company's future, potentially boosting investor sentiment.

Key Dates

Recommendation

The acquisition of additional deferred stock units by Elanco's President and CEO, Jeffrey N. Simmons, signals strong insider confidence in the company's future. This aligns management's interests with shareholders and is generally a positive indicator. However, without broader financial performance data or strategic updates, this single transaction primarily reinforces a 'hold' position for investors, suggesting continued confidence rather than a new catalyst for a 'buy' recommendation.

Keywords

Elanco Animal Health Inc., ELAN, Jeffrey N. Simmons, Insider Trading, Form 4, Deferred Stock Units, Executive Compensation, Stock Ownership